Safrazine is a member of the hydrazine family with non-selective and irreversible inhibitor effects against monoamine oxidases. In 1960, it was used as an antidepressant but it is now discontinued.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Magnesium sulfate | The therapeutic efficacy of Safrazine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Safrazine may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Orphenadrine | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Safrazine. |
| Pramipexole | Safrazine may increase the sedative activities of Pramipexole. |
| Ropinirole | Safrazine may increase the sedative activities of Ropinirole. |
| Rotigotine | Safrazine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Safrazine. |
| Sodium oxybate | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Thalidomide | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Safrazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Desmopressin | The risk or severity of hypertension can be increased when Desmopressin is combined with Safrazine. |
| Cyclosporine | The risk or severity of hypertension can be increased when Cyclosporine is combined with Safrazine. |
| Icosapent | The risk or severity of hypertension can be increased when Icosapent is combined with Safrazine. |
| Mesalazine | The risk or severity of hypertension can be increased when Mesalazine is combined with Safrazine. |
| Indomethacin | The risk or severity of hypertension can be increased when Indomethacin is combined with Safrazine. |
| Methylergometrine | The risk or severity of hypertension can be increased when Methylergometrine is combined with Safrazine. |
| Nabumetone | The risk or severity of hypertension can be increased when Nabumetone is combined with Safrazine. |
| Ketorolac | The risk or severity of hypertension can be increased when Ketorolac is combined with Safrazine. |
| Tenoxicam | The risk or severity of hypertension can be increased when Tenoxicam is combined with Safrazine. |
| Celecoxib | The risk or severity of hypertension can be increased when Celecoxib is combined with Safrazine. |
| Tolmetin | The risk or severity of hypertension can be increased when Tolmetin is combined with Safrazine. |
| Rofecoxib | The risk or severity of hypertension can be increased when Rofecoxib is combined with Safrazine. |
| Piroxicam | The risk or severity of hypertension can be increased when Piroxicam is combined with Safrazine. |
| Fenoprofen | The risk or severity of hypertension can be increased when Fenoprofen is combined with Safrazine. |
| Valdecoxib | The risk or severity of hypertension can be increased when Valdecoxib is combined with Safrazine. |
| Diclofenac | The risk or severity of hypertension can be increased when Diclofenac is combined with Safrazine. |
| Sulindac | The risk or severity of hypertension can be increased when Sulindac is combined with Safrazine. |
| Nicergoline | The risk or severity of hypertension can be increased when Nicergoline is combined with Safrazine. |
| Flurbiprofen | The risk or severity of hypertension can be increased when Flurbiprofen is combined with Safrazine. |
| Etodolac | The risk or severity of hypertension can be increased when Etodolac is combined with Safrazine. |
| Mefenamic acid | The risk or severity of hypertension can be increased when Mefenamic acid is combined with Safrazine. |
| Naproxen | The risk or severity of hypertension can be increased when Naproxen is combined with Safrazine. |
| Sulfasalazine | The risk or severity of hypertension can be increased when Sulfasalazine is combined with Safrazine. |
| Phenylbutazone | The risk or severity of hypertension can be increased when Phenylbutazone is combined with Safrazine. |
| Meloxicam | The risk or severity of hypertension can be increased when Meloxicam is combined with Safrazine. |
| Carprofen | The risk or severity of hypertension can be increased when Carprofen is combined with Safrazine. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Safrazine. |
| Diflunisal | The risk or severity of hypertension can be increased when Diflunisal is combined with Safrazine. |
| Salicylic acid | The risk or severity of hypertension can be increased when Salicylic acid is combined with Safrazine. |
| Meclofenamic acid | The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Safrazine. |
| Dopamine | The risk or severity of hypertension can be increased when Dopamine is combined with Safrazine. |
| Oxaprozin | The risk or severity of hypertension can be increased when Oxaprozin is combined with Safrazine. |
| Ketoprofen | The risk or severity of hypertension can be increased when Ketoprofen is combined with Safrazine. |
| Balsalazide | The risk or severity of hypertension can be increased when Balsalazide is combined with Safrazine. |
| Ibuprofen | The risk or severity of hypertension can be increased when Ibuprofen is combined with Safrazine. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Safrazine. |
| Propafenone | The risk or severity of hypertension can be increased when Propafenone is combined with Safrazine. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Safrazine. |
| Lumiracoxib | The risk or severity of hypertension can be increased when Lumiracoxib is combined with Safrazine. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Safrazine. |
| Magnesium salicylate | The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Safrazine. |
| Salsalate | The risk or severity of hypertension can be increased when Salsalate is combined with Safrazine. |
| Choline magnesium trisalicylate | The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Safrazine. |
| Antrafenine | The risk or severity of hypertension can be increased when Antrafenine is combined with Safrazine. |
| Aminophenazone | The risk or severity of hypertension can be increased when Aminophenazone is combined with Safrazine. |
| Antipyrine | The risk or severity of hypertension can be increased when Antipyrine is combined with Safrazine. |
| Tiaprofenic acid | The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Safrazine. |
| Etoricoxib | The risk or severity of hypertension can be increased when Etoricoxib is combined with Safrazine. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Safrazine. |
| Taxifolin | The risk or severity of hypertension can be increased when Taxifolin is combined with Safrazine. |
| Oxyphenbutazone | The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Safrazine. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Safrazine. |
| Benoxaprofen | The risk or severity of hypertension can be increased when Benoxaprofen is combined with Safrazine. |
| Metamizole | The risk or severity of hypertension can be increased when Metamizole is combined with Safrazine. |
| Zomepirac | The risk or severity of hypertension can be increased when Zomepirac is combined with Safrazine. |
| Dronedarone | The risk or severity of hypertension can be increased when Dronedarone is combined with Safrazine. |
| Cimicoxib | The risk or severity of hypertension can be increased when Cimicoxib is combined with Safrazine. |
| Amibegron | The risk or severity of hypertension can be increased when Amibegron is combined with Safrazine. |
| Nylidrin | The risk or severity of hypertension can be increased when Nylidrin is combined with Safrazine. |
| Solabegron | The risk or severity of hypertension can be increased when Solabegron is combined with Safrazine. |
| Lornoxicam | The risk or severity of hypertension can be increased when Lornoxicam is combined with Safrazine. |
| Aceclofenac | The risk or severity of hypertension can be increased when Aceclofenac is combined with Safrazine. |
| Zaltoprofen | The risk or severity of hypertension can be increased when Zaltoprofen is combined with Safrazine. |
| Saralasin | The risk or severity of hypertension can be increased when Saralasin is combined with Safrazine. |
| Azapropazone | The risk or severity of hypertension can be increased when Azapropazone is combined with Safrazine. |
| Parecoxib | The risk or severity of hypertension can be increased when Parecoxib is combined with Safrazine. |
| Salicylamide | The risk or severity of hypertension can be increased when Salicylamide is combined with Safrazine. |
| Tyramine | The risk or severity of hypertension can be increased when Tyramine is combined with Safrazine. |
| Mirabegron | The risk or severity of hypertension can be increased when Mirabegron is combined with Safrazine. |
| Adrafinil | The risk or severity of hypertension can be increased when Adrafinil is combined with Safrazine. |
| Kebuzone | The risk or severity of hypertension can be increased when Kebuzone is combined with Safrazine. |
| Isoxicam | The risk or severity of hypertension can be increased when Isoxicam is combined with Safrazine. |
| Indoprofen | The risk or severity of hypertension can be increased when Indoprofen is combined with Safrazine. |
| Ibuproxam | The risk or severity of hypertension can be increased when Ibuproxam is combined with Safrazine. |
| Floctafenine | The risk or severity of hypertension can be increased when Floctafenine is combined with Safrazine. |
| Fenbufen | The risk or severity of hypertension can be increased when Fenbufen is combined with Safrazine. |
| Etofenamate | The risk or severity of hypertension can be increased when Etofenamate is combined with Safrazine. |
| Etilefrine | The risk or severity of hypertension can be increased when Etilefrine is combined with Safrazine. |
| Epirizole | The risk or severity of hypertension can be increased when Epirizole is combined with Safrazine. |
| Benzydamine | The risk or severity of hypertension can be increased when Benzydamine is combined with Safrazine. |